title: Clinical isolation of Nocardia cyriacigeorgica from patients with various clinical manifestations, the first report from Iran.
abstract: We herein describe five various cases of human infections by Nocardia cyriacigeorgica. The identification included conventional and molecular sequencing tests. The current study provides further evidences that N. cyriacigeorgica species is a ubiquitous organism capable of establishing long-term infection in healthy and immunocompromised patients.
authors: Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
authors: Hasan
authors: H
authors: Shojaei
authors: Abdolrazagh
authors: A
authors: Hashemi
authors: Parvin
authors: P
authors: Heidarieh
authors: Saeid
authors: S
authors: Eshraghi
authors: Ali-Reaza
authors: AR
authors: Khosravi
authors: Abass
authors: A
authors: Daei Naser
mesh_terms: D000368:Aged; D000583:Amikacin / Q000008:administration & dosage; D000890:Anti-Infective Agents / Q000008:administration & dosage; D001426:Bacterial Proteins / Q000235:genetics; D004269:DNA, Bacterial / Q000235:genetics; D004275:DNA, Ribosomal / Q000235:genetics; D005260:Female; D006360:Heat-Shock Proteins / Q000235:genetics; D006801:Humans; D016867:Immunocompromised Host; D007492:Iran; D008297:Male; D008875:Middle Aged; D009615:Nocardia / Q000235:genetics / Q000302:isolation & purification* / Q000472:pathogenicity; D009617:Nocardia Infections / Q000188:drug therapy / Q000382:microbiology*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA; D013420:Sulfamethoxazole / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage
chemical_list: D000890:Anti-Infective Agents; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D006360:Heat-Shock Proteins; D012336:RNA, Ribosomal, 16S; D000583:Amikacin; D014295:Trimethoprim; D013420:Sulfamethoxazole